Leads Biolabs Completes H-Share Full Circulation, Free-Float Rises to 99.39%

Bulletin Express06-05

Nanjing Leads Biolabs Co., Ltd. (Leads Biolabs) announced the successful completion of its H-share full circulation programme, converting 44.39 million previously unlisted domestic shares into H shares on 4 June 2026. The newly converted shares began trading on the Hong Kong Stock Exchange at 09:00 on 5 June 2026.

Post-conversion, Leads Biolabs’ capital structure remains unchanged at 198.89 million shares, but the composition has shifted markedly. H shares now account for 197.67 million, representing 99.39 % of total issued capital, up from 77.07 % prior to the transaction. Unlisted domestic shares have correspondingly fallen to 1.22 million, or 0.61 % of the total, from 22.93 % previously.

The board advised shareholders and potential investors to exercise caution when dealing in the company’s securities.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1113955695?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-05 20:04","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1113955695","market":"us","top_or_hot":-1,"title":"Leads Biolabs Completes H-Share Full Circulation, Free-Float Rises to 99.39%","media":"Bulletin Express","content":"<p>Nanjing Leads Biolabs Co., Ltd. (Leads Biolabs) announced the successful completion of its H-share full circulation programme, converting 44.39 million previously unlisted domestic shares into H shares on 4 June 2026. The newly converted shares began trading on the Hong Kong Stock Exchange at 09:00 on 5 June 2026.</p>\n<p>Post-conversion, Leads Biolabs’ capital structure remains unchanged at 198.89 million shares, but the composition has shifted markedly. H shares now account for 197.67 million, representing 99.39 % of total issued capital, up from 77.07 % prior to the transaction. Unlisted domestic shares have correspondingly fallen to 1.22 million, or 0.61 % of the total, from 22.93 % previously.</p>\n<p>The board advised shareholders and potential investors to exercise caution when dealing in the company’s securities.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Leads Biolabs Completes H-Share Full Circulation, Free-Float Rises to 99.39%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLeads Biolabs Completes H-Share Full Circulation, Free-Float Rises to 99.39%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-06-05 20:04</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Nanjing Leads Biolabs Co., Ltd. (Leads Biolabs) announced the successful completion of its H-share full circulation programme, converting 44.39 million previously unlisted domestic shares into H shares on 4 June 2026. The newly converted shares began trading on the Hong Kong Stock Exchange at 09:00 on 5 June 2026.</p>\n<p>Post-conversion, Leads Biolabs’ capital structure remains unchanged at 198.89 million shares, but the composition has shifted markedly. H shares now account for 197.67 million, representing 99.39 % of total issued capital, up from 77.07 % prior to the transaction. Unlisted domestic shares have correspondingly fallen to 1.22 million, or 0.61 % of the total, from 22.93 % previously.</p>\n<p>The board advised shareholders and potential investors to exercise caution when dealing in the company’s securities.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09887","symbol_name":"维立志博-B","start_time":0,"source_url":"","article_id":"1113955695","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1113955695","pubTimestamp":1780661065,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Nanjing Leads Biolabs Co., Ltd. (Leads Biolabs) announced the successful completion of its H-share full circulation programme, converting 44.39 million previously unlisted domestic shares into H...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"09887":"维立志博-B"},"translate_title":"先导生物完成H股全流通自由流通股升至99.39%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09887":1},"content_text":"Nanjing Leads Biolabs Co., Ltd. (Leads Biolabs) announced the successful completion of its H-share full circulation programme, converting 44.39 million previously unlisted domestic shares into H shares on 4 June 2026. The newly converted shares began trading on the Hong Kong Stock Exchange at 09:00 on 5 June 2026.\nPost-conversion, Leads Biolabs’ capital structure remains unchanged at 198.89 million shares, but the composition has shifted markedly. H shares now account for 197.67 million, representing 99.39 % of total issued capital, up from 77.07 % prior to the transaction. Unlisted domestic shares have correspondingly fallen to 1.22 million, or 0.61 % of the total, from 22.93 % previously.\nThe board advised shareholders and potential investors to exercise caution when dealing in the company’s securities.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1113955695","isCrawlerRequest":true}